Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
- Status
- TERMINATED
- Phase
- PHASE2
Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Minocycline to Treat Central Retinal Vein Occlusion
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Minocycline to Treat Branch Retinal Vein Occlusion
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE2
Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue
- Status
- TERMINATED
- Phase
- PHASE2
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2